Why Your Dexmethylphenidate Label Says "50-50"
The "50-50" on your Focalin XR (dexmethylphenidate extended-release) label refers to the bimodal drug delivery system: each capsule contains 50% immediate-release beads and 50% delayed-release beads. 1
How the Formulation Works
Focalin XR uses proprietary SODAS (Spheroidal Oral Drug Absorption System) technology that creates a dual-release pattern:
- First 50%: Immediate-release beads that dissolve right away (peak at ~1.5 hours)
- Second 50%: Enteric-coated, delayed-release beads that activate approximately 4 hours later (second peak at ~6.5 hours)
This 50-50 split mimics taking two separate doses of immediate-release dexmethylphenidate 4 hours apart, but in a single capsule 1, 2.
Clinical Significance
This bimodal design provides symptom control throughout the school/work day (up to 12 hours) with once-daily dosing 3, 4. The formulation creates two distinct plasma concentration peaks rather than a single sustained level, which:
- Provides rapid symptom control within 30 minutes of administration
- Maintains therapeutic levels through midday without requiring a school-administered dose
- Extends coverage into afternoon/early evening activities
The pharmacokinetic profile shows the first peak occurs at 1-4 hours post-dose, followed by an interpeak minimum, then a second peak at 4.5-7 hours 1, 5.
Practical Implications
For patients unable to swallow capsules, the beads can be sprinkled on applesauce without affecting the 50-50 release pattern 1, 6. The enteric coating on the delayed-release beads remains intact, preserving the bimodal delivery.
The 50-50 formulation means that a 20 mg Focalin XR capsule delivers the same total amount of dexmethylphenidate as taking 10 mg immediate-release tablets twice daily, 4 hours apart 1.